Need more? Try out  Advanced Search (20+ criteria)»

Last Update

is this you? Claim your profile.

Wrong Mimoun Azzouz?

Mimoun Azzouz

Director of Neurobiology

Oxford BioMedica plc

HQ Phone:  +44 1865 783000

Email: m***@***.uk

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Oxford BioMedica plc

Windrush Court Transport Way

Oxford, Oxfordshire,OX4 6LT

United Kingdom

Company Description

Oxford BioMedica plc (LSE: OXB) is a leading gene and cell therapy group with an unrivalled portfolio of gene therapy products in development and a platform of exclusive and pioneering technologies with which it designs, develops and manufactures unique gene-b... more.

Find other employees at this company (205)

Background Information

Employment History

Chair of Translational Neuroscience

Sheffield Institute for Translational Neuroscience


Visiting Scientist

Oxford University


Post Doctoral Scientist

Gene Therapy Center


Abstract Reviewer

The American Society of Gene & Cell Therapy


Affiliations

The University of Sheffield

ERC Advanced Fellow


Medical Research Council

Member


Research Council of Norway

Member


French Muscular Dystrophy Association

Member


Education

Biology and Neuroscience

University of Rabat


Master

Neuroscience

University of Marseille


PhD

Neuropharmacology

University Louis Pasteur


Web References(34 Total References)


SITraN - The University of Sheffield

sitran.dept.shef.ac.uk [cached]

Professor Mimoun Azzouz | more
SITraN - The University of Sheffield The University of Sheffield Professor Azzouz has a long-standing interest in developing gene therapy approaches for neurodegenerative diseases. Azzouz' team utilises viral based gene transfer systems both for research and gene therapy applications. Such viral systems have included lentiviruses and adeno-associated vectors. His research focuses on developing new therapeutic strategies for motor neuron diseases (ALS and SMA) and Parkinson's disease. He also collaborates with other groups looking at new experimental approaches to treatment of Alzheimer's disease and multiple sclerosis. Members of the team are also investigating molecular pathways and signalling of motor neuron death associated with ALS and SMA. Background Information Professor Azzouz graduated in Biology and Neuroscience from the University of Rabat in 1993. He obtained a Master in Neuroscience with 1st Class Honours from the University of Marseille in 1994. In 1997 he was awarded a PhD in Neuropharmacology at the University Louis Pasteur in Strasbourg. He then worked as post doctoral scientist at the Gene Therapy Center in Lausanne, Switzerland from 1997 to 2000. He was recruited in 2000 by Oxford BioMedica Ltd as Senior Scientist then appointed as Director of Neurobiology in 2003. He was also a visiting scientist at Oxford University between 2000 and 2005. In 2006 he was appointed Professor of Translational Neuroscience at the University of Sheffield. Current Research Professor Azzouz is currently using his expertise in neuroscience and gene therapy to develop therapies for motor neuron diseases. He is a Chair of Translational Neuroscience at the University of Sheffield and formerly Director of Neurobiology at Oxford BioMedica Ltd. Since his appointment to the Chair of Translational Neuroscience, in 2006, he assembled an excellent research team and has been successful in attracting an array of scientific funding from prestigious national and international funding bodies. His current research in the newly established gene therapy laboratory is focused on four major objectives: Professor Azzouz has an excellent publication track record. He published papers in high profile and prestigious journals such as Nature, Nature Medicine, Nature Neuroscience, Science Translational Medicine. Azzouz has led the field internationally in developing and evaluating gene therapy approaches using viral vectors, with the potential for exciting new therapeutic approaches in neurodegenerative diseases. Gene therapy in models of Parkinson's disease (PD) is already translating into human clinical trials and a new SMN replacement strategy is currently entering clinical development for SMA patients. He has been successful in attracting an array of scientific awards including the prestigious ERC Advanced Investigator Award. This award is a top level EU ad hominem award acknowledging his pre-eminence in European biomedical research. Professor Azzouz is advisor for pharmaceutical companies (BioMarin Pharmaceutical Inc, Oxford BioMedica Ltd). He is member of scientific advisory panel for various funding bodies such as the Medical Research Council (MRC), the French Muscular Dystrophy Association and The Research Council of Norway. Professor Azzouz's research is funded by the Medical Research Council, Jennifer Trust, EPSRC, AFM, SMA Europe, ERC Advanced Award and MRC DPFS.


Motor Neurone Disease Association is a charity dedicated to support people with MND

domain633080.sites.fasthosts.com [cached]

The research was led by Dr Mimoun Azzouz, Director of Neurobiology, at leading gene therapy company, Oxford BioMedica in collaboration with the Center for Transgene Technology and Gene Therapy in Belgium.


Prelude Ventures : Portfolio News : UK Scientists Pioneer Novel Treatment For Motor Neuron Disease

www.prelude-ventures.com [cached]

The research was led by Dr Mimoun Azzouz, Director of Neurobiology at Oxford BioMedica, in collaboration with the VIB department for Transgene Technology and Gene Therapy in Belgium.


Oxford BioMedica

www.oxfordbiomedica.co.uk [cached]

The research was led by Dr Mimoun Azzouz, Director of Neurobiology at Oxford BioMedica, in collaboration with the VIB department for Transgene Technology and Gene Therapy in Belgium.


Oxford BioMedica

www.oxfordbiomedica.co.uk [cached]

The research was led by Dr Mimoun Azzouz, Director of Neurobiology at Oxford BioMedica, in collaboration with the VIB department for Transgene Technology and Gene Therapy in Belgium.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory